Metabolic syndrome: evaluation of pathological and therapeutic outcomes

Am Heart J. 2005 Jan;149(1):20-32. doi: 10.1016/j.ahj.2004.07.012.
No abstract available

Publication types

  • Congress

MeSH terms

  • Arteriosclerosis / diagnostic imaging
  • Arteriosclerosis / etiology*
  • Arteriosclerosis / physiopathology
  • Clinical Trials as Topic
  • Cost-Benefit Analysis
  • Diabetes Complications
  • Endothelium, Vascular / physiopathology
  • Health Care Costs
  • Humans
  • Hypertension / complications
  • Hypoglycemic Agents / therapeutic use
  • Life Style
  • Lipoproteins / physiology
  • Metabolic Syndrome / drug therapy
  • Metabolic Syndrome / therapy*
  • Metformin / therapeutic use
  • Peroxisome Proliferator-Activated Receptors / agonists*
  • Radiography
  • Risk Factors
  • Ultrasonography

Substances

  • Hypoglycemic Agents
  • Lipoproteins
  • Peroxisome Proliferator-Activated Receptors
  • Metformin